Year 2008 |
* |
DTAB finds
most of the contentious 294 FDC drugs 'illogical' |
* |
Finance ministry
refuses to review tax-exemption scheme for SSIs |
* |
Govt to reimburse
75% of expenses incurred for ISO certification of pharma, biotech units
|
* |
NPPA fixes
prices of 1009 formulations under pro-rata norms |
* |
Indian
Pharmacopoeia 2007 to be made effective only from July |
* |
Excise cut in
Union budget may bring down prices of only 10% of medicines |
* |
SPIC calls for
a pro-SME attitude by NIPER to improve SSI status |
* |
Health ministry
bans use of prefixes, suffixes with classical ASU formulation name |
* |
NPPA starts
scrutiny of scheduled drugs' prices to see 4.58 per cent reduction in MRP
by pharma cos |
* |
Pharma SMEs
lack expertise, finance for adoption of good manufacturing practices: DSIR
|
* |
CIPI asks members
to reduce prices of medicines in lieu of excise cut |
* |
Change of guard
at DCGI office leads to piling up of applications: Industry |
* |
Stalemate over
issuing licenses to FDCs with no directive from DCGI |
* |
CIPI asks member
companies to voluntarily withdraw absurd combinations |
* |
Small cos will
continue to get credit subsidy |
* |
CIPI to approach
finance ministry to relax norms in PTUF Scheme |
* |
Chemicals ministry
to ask drug units to pass on excise cut on non scheduled drugs too |
* |
NPPA asks manufacturers
to reduce prices of scheduled drugs by 5% following cut in excise duty |
* |
Industry hails
excise duty reduction, disappointed on lack of major R&D sops |
* |
Pharma associations
by and large welcome Union Budget |
* |
Finance Minister
brings cheers to pharma industry |
* |
NPPA gets ISO
certificate, launches online compliant facility, industry directory
|
* |
GoM to clear
pharmaceutical policy at next meeting scheduled in March 2nd week |
* |
Chemicals ministry
moots excise exemption to 354 NLEM drugs |
* |
NPPA plans pro-rata
pricing on creams, ointments in tubes to check price dodging |
* |
Chemicals ministry
may impose 8 % excise on pharma units in hill states |
* |
New drug policy
may not widen price control list |
* |
Punjab govt
may move SC against tax holiday schemes in some states |
* |
Stay on DCGI
order may continue as the court is yet to list the cases |
* |
CIPI may withdraw
cases if DCGI allows 150 FDCs to be marketed |
* |
CIPI pleads
govt to treat formulation units differently from bulk drug sector |
* |
Industry bodies
may move court against NPPA's "anti-industry approach" |
* |
Planning Commission
may sanction setting of DPCO cells in all states soon |
* |
NPPA introduces
pro-rata pricing for oral liquid preparations |
* |
CIPI to meet
new DCGI on Feb 8 to have a 'settlement' on FDC issue |
* |
Dr Surinder
Singh, new DCGI promises interactive approach with industry |
* |
Dr Venkateshwarlu's
exit may slow down action on FDC s |
* |
Dr Surinder
Singh appointed new DCGI from today |
* |
Third meeting
of GoM on pharma policy makes no headway |
* |
Gujarat FDCA
seeking legal opinion for further action on FDC drugs |
* |
Finance ministry
withdraws excise exemption for peripheral units in all states |
* |
Industry finds fault with Ramadoss'
statement on CDA |
* |
Chemical ministry
moots scraping of duty exemption to contract units in excise-free zones |
* |
Pharma cos resume
production of FDC drugs in small quantities |
* |
Pharma associations
pitch for cut in excise duty as Fin Minister begins pre-budget talks |
* |
Industry ready
for talks with DCGI again to settle FDC issue |
* |
NPPA may review
10% ceiling on hike in prices of non-scheduled drugs |
| |
Year 2007 |
* |
Gujarat Pharma
industry to celebrate 100 years of existence |
* |
DCGI still
ready for further talks with industry on FDC issue |
* |
Doctors still
ignorant about campaign to weed out irrational combinations |
* |
Public interest
groups to move court seeking to weed out 294 irrational combinations |
* |
Madras HC admits
drug regulator’s counter plea |
* |
Under industry
pressure, AP DC allows marketing of 294 FDCs in state |
* |
Chemicals ministry
opposes proposal for separate pharma ministry |
* |
Union Health
and Family Welfare Minister Anbumani Ramadoss will release the Indian Pharmacopoeia
2007 here tomorrow. |
* |
Fee for GMP
certification, hike of all other fees likely once CDAI starts operations
|
* |
State drug
authorities working on different directions as chaos prevails over 294 FDCs
|
* |
Haryana drug
controller allows pharma cos to resume manufacture of FDC drugs |
* |
Indian Pharmacopoeia
2007 edition ready for release on Dec 18 |
* |
DCGI to file
counter-affidavit in Madras High Court today |
* |
Drug Prices
fixed under DPCO 1995 have to be Mandatorily Implemented |
* |
Finance ministry
against creating additional posts for CDAI, suggests outsourcing |
* |
Chemicals, Finance
ministries want more enforcement powers to SLAs under CDA |
* |
DCGI to file
counter affidavit in Madras HC on stay orders on FDC issue |
* |
NPPA
fixes price for formulation packs; revises conversion, packaging costs
|
* |
Madras HC now
stays DCGI order under 33(p) of D&C Act |
* |
Maharashtra
FDA fully in compliance with DCGI order |
* |
Drug
makers may fall under NDPS Act |
* |
DCGI decides
to invoke section 33 (p) of D&C Act to enable state DCs act on FDCs
|
* |
Madras High Court once
again stays DCGI order, now on CIPI's petition |
* |
Maharashtra
FDA may ignore Madras HC stay, to commence action on FDC drugs |
* |
DCGI approved
many drugs without safety trails |
* |
Pharma cos turn
cautious, not to make 294 FDCs despite Madras HC stay |
* |
DCGI likely
to invoke special provisions to ban 294 drugs |
* |
DCGI to file
counter petition in Madras HC soon |
* |
DCGI may move
Supreme Court on FDC issue if drug cos resist |
* |
Pharma cos see
legal way out of combo ban |
* |
DCGI brief on
FDCs reaches state drug depts, silent on action at retail level |
* |
DCGI allows
selling of 150 'under examination' FDCs lying with retailers till expiry
|
* |
How serious
a threat are combination drugs? |
* |
Chemicals ministry
preparing Cabinet note seeking excise at 8 % in pharma sector |
* |
DCGI-industry
friction arises on withdrawal of 150 FDCs at Chandigarh meet |
* |
MSCDA urges
FDA to give a time frame to cos to withdraw irrational FDCs |
* |
DCGI-Industry
talk fails to resolve FDC issue |
* |
DCGI calls meeting
of pharma assns to discuss FDC issue on Oct 27 |
* |
DCGI to clear
files for licenses for FDCs by Oct 26 |
* |
DCGI may allow
marketing of state approved FDCs with proven rationality |
* |
Drug controllers
of southern states not acting on DCGI order on FDCs |
* |
DCGI to review
actions by state controllers on FDC issue on Oct 25 |
* |
DCGI working
on policy guidelines on Fixed Dose Combinations |
* |
Industry leaders
to meet Health Minister on irrational combination issue soon |
* |
NPPA revises
prices of 164 formulation packs |
* |
DCGI to file
caveat in all HCs against granting stay in irrational combination cases |
* |
Staff shortage
may slower withdrawal of irrational drugs from market |
* |
Chemicals ministry
to set up price monitoring cells in all States under new policy |
* |
Drug companies
indulge in use of labels of excise free states to evade tax |
* |
Paswan wants
industry to co-operate with drug price reduction |
* |
Drug cos train
guns at GoM, NPPA over pricing policy |
* |
Combination
drugs a crime on society: DCGI |
* |
Companies gearing
up to move court on combination drug issue, one company gets stay |
* |
Drug controllers
for giving more time to manufacturers to withdraw combination drugs |
* |
Health Ministry
finalises new bill to counter spurious drugs with stricter penalties |
* |
GoM to consult
consumer society of India before finalising policy |
* |
Chemicals ministry
collecting data to hike abatement to SSIs |
* |
GoM meet fails
to make any headway on pharma policy |
* |
Pharma cos want
fewer price controls |
* |
GoM on pharma
policy meets industry, consumer bodies |
* |
Create ministry
for pharmaceutical sector |
* |
State drug
controllers competent to issue licenses for combination drugs: IDMA |
* |
State FDA issues
stop production orders on 330 combination drugs, all 7 JCs alerted |
* |
DCGI to meet
state controllers soon to press weeding out of irrational combinations |
* |
GOM to invite
industry associations for meeting on Sept 12 |
* |
GoM invites
CII for 2nd meeting on Sept 12, industry assns not called |
* |
Report on
Two days workshop on "Draft- National Pharmaceutical Policy 2006”
Organised by Indian Pharmaceutical Association, M. P. State Branch on 8-9th
Sept. 2007 at Hotel Sayaji, Indore |
* |
Pharma assns ask DCGI to see
reason in withdrawing irrational drugs from market |
* |
No information
about banned drugs available in the country: Ramadoss |
* |
Govt may not
succeed to mop up revenue from excise free zones after excise withdrawal
|
* |
Excise or no
excise? |
* |
Allow fixed
drug combos for now : IPA |
* |
Pharma cos to
withdraw irrational products soon as state drug authorities set for action |
* |
NPPA calls for
price check on Albendazole |
* |
Pharma cos to
challenge DCGI order seeking withdrawal of irrational combinations |
* |
Contract units
oppose move to withdraw excise exemption in Himachal, Uttarakhand |
* |
AP govt assures
BDMA of measures to prevent migration of industries |
* |
Shortage of widely
used antibiotics likely as formulators threaten to stop production |
* |
Finance ministry
rejects SSIs demand for higher abatement rate |
* |
Govt may reconsider
cutting excise duty from 16% on pharma industry |
* |
The
National Pharmaceutical Pricing Authority has fixed / revised the prices
in respect of 130 formulation packs vide notifications
/ orders dated 1.8.2007. |
* |
SSIs complain
against big pharma for branding them as fake drug makers in news channel
|
* |
Karunanidhi
offers to help SSIs over excise withdrawal issue, CIPI now neutral |
* |
Excise Free
Zone - Myth or Reality |
* |
Units in excise
free states threaten to move SC if govt withdraws excise exemption
|
* |
DCGI order
to withdraw 1105 irrational combination drugs missing
|
* |
Govt working
on US-style authority for drug control |
* |
Govt launches
e-filing prog for patent, trademarks |
* |
Himachal CM
to meet PM, Sonia on excise withdrawal issue |
* |
Excise withdrawal
move in HP, Uttarakhand stuck with finance ministry despite PM's letter |
* |
Govt may ask
industry to give medicine at half rate for health insurance schemes for
poor |
* |
Tax holiday
withdrawal haunts pharma in Himachal |
* |
Contract units
of Himachal, Uttarakhand plans shifting to J&K fearing excise withdrawal |
* |
Pharma industry
opposes the move to weed out irrational drug combinations |
* |
SSI bodies
outside excise free states seek PM's help to stop excise exemption to contract
units |
* |
Contract units
in Himachal,Uttarakhand oppose move to withdraw excise exemption
|
* |
Finance ministry
puts up fresh roadblocks to delay sops for small scale sector |
* |
NIPER subcommittee
may recommend discount to SME sector on consultancy fees |
* |
Several irrational
combinations may bypass DCGI's list of 1015 drugs |
* |
US pharma industry
raps India's draft pharma policy |
* |
Price control
to cover only 200 drugs in new pharmaceutical policy |
* |
Industry puts
onus on state drug depts to prove combination drugs as irrational |
* |
Centre to order
withdrawal of licence to thousands of 'irrational' combination drugs |
* |
Revised Consultancy
Rules of NIPER |
* |
Centre fails
to remove excise exemption to contract units despite PM's order |
* |
SSI Ministry
may seek continuation of CLCSS for small-scale units |
* |
Law min seeks
relief for SME pharmas |
* |
NPPA has fixed/revised
the price in respect of 94 formulation packs on 5th June, 2007 |
* |
Industry assns
to revive demand for cut in excise duty from 16 to 8 % |
* |
SSIs seeks support
of more MPs for getting exemption from Schedule M norms |
* |
NPPA finds
pharma cos hiked prices of 103 formulation packs beyond 10% |
* |
SSIs urge PM
to implement EAC recommendation on abatement |
* |
Service tax
on contract manufacturers in excise free states likely soon |
* |
Delay in GoM
meetings hold up finalization of pharma policy, no idea of 2nd meeting |
* |
SSIs upset over
SIDBI's withdrawal of technology upgradation scheme |
* |
MRP-based tax
regime - Pharma sector revenue dips |
* |
Gujarat Biotech
Park at Vadodara set to commence operations, waiting for Centre's nod |
* |
IPC to publish
latest version of Indian Pharmacopoeia in June 2007 |
* |
Voluntary
E-filing system for NPPA Applications |
* |
Over 800 SSI
pharma units from 15 states implement Schedule M, Gujarat tops list
|
* |
Chemicals Ministry
to review voluntary price cut by pharma companies |
* |
Gujarat govt
announces incentives for biotech in BT Policy 2007-2012 |
* |
CIPI demands
immediate withdrawal of MRP-based excise to save SSIs |
* |
Pharma firms
likely to face MRTPC inquiry |
* |
Excise Duty
Exemption for North East Extended |
* |
Pharma assns
to informally meet GoM members to mould their views |
* |
Centre
to lose Rs 1000 cr in excise from drug units in Baddi, Uttarakhand this
year |
* |
Govt slaps
notice on pharma cos for overcharging |
* |
Pharma excise
collections hit a low |
* |
Pharma industry
to get formal invite to present views before full GoM panel |
* |
FSSPII urges
GoM to exempt old SSIs from revised schedule M |
* |
NPPA product
prescript cures pharmas’ SSI misuse malady |
* |
PDMA seeks
PM's role to implement Dr Rangarajan report seeking to raise abatement to
60% |
* |
OPPI wants
to go with CIPI, IDMA to meet GOM on new drug policy |
* |
Pharma assns
to oppose govt move to expand price control at next GoM meeting |
* |
SSIs upset over
less time granted by govt to submit data for deciding abatement rate |
* |
Draft amendment
to labelling rules to be notified soon, panel report almost ready |
* |
CIPI asks govt
to accord special status to small formulation units |
* |
NPPA may lose
some autonomy |
* |
After 3 months,
GoM to meet on pharma policy on April 10 |
* |
NPPA fixes prices of 12 formulation
packs, revises price for 73 in total |
* |
OPPI to oppose
govt move for price control on patented drugs |
* |
Govt to look
into denial of export credit to SSIs, export lending to pharma exceeds 30
% in 2006 |
* |
A new products
fee charged by AIOCD puts SSIs in serious trouble |
* |
Dr Mashelkar resigns as TEG
chairman |
* |
NPPA to take
action on cos raising prices of decontrolled drugs over 10 % a year |
* |
Finance ministry
may consider hike in abatement rate to pharma SSIs soon |
* |
Pharma Industry,
Be Happy--Somebody Cares |
* |
CIPI approaches
Centre for simplification of procedures for sanctioning of upgradation fund |
* |
Pharmaceutical
industry resents added tax |
* |
CIPI calls upon
its members to 'come together or perish' |
* |
SSIs disappointed
over budget: PMA |
* |
Budget not
industry friendly: AP pharma industry |
* |
Budget a big
let down for pharma industry: Associations |
* |
Pharma cos disappointed
with no expected cut in excise duty in Budget 2007 |
* |
Pharma policy
to be implemented soon: Survey |
* |
OPPI appeals
for R&D incentives, cut in excise duty in Union budget |
* |
Pharma companies
exploit new MRP system to raise prices irrationally |
* |
NPPA revises
prices of 193 formulation packs |
* |
NPPA revises
prices of tolnaftate and ephedrine derivatives |
* |
Excise duty
cut, R&D sops high on drug cos’ wish-list |
* |
Pharma industry
rues govt failure to provide relief |
* |
Gujarat FDA
to launch fully computerised licensing system by next week |
* |
Tehelka
Story on MRP based excise |
* |
IDMA seeks cut
in excise duty for pharma |
* |
What the proposed
central drug regulator should do? |
* |
Sharad Pawar
to head GoM on pharma policy |
* |
CIPI wants higher
abatement for SSIs to be included in Budget 2007 |
* |
Centralized
licensing to be implemented in 5-year span on therapeutic basis |
* |
Small pharma
cos, a section of doctors welcome OPPI code for marketing of drugs |
* |
OPPI warns members
of action for breaching code of marketing practices |
* |
CIPI asks govt
to limit higher abatement rate to only SSIs |
* |
Panel of Group
of Ministers reviewing draft policy to be announced by PMO soon |
* |
Cabinet approves
CDA by amending DCAct |
* |
Pharma industry
urges finance ministry R&D sops, higher abatement in pre budget talks |
* |
Govt may drop
move for centralization of licensing ISM drugs |
* |
New pharma policy
to streamline branding of drugs |
* |
Levofloxacin:
dysglycemia and liver disorders |
* |
Finance Ministry
may grant higher abatement rate for drugs soon |
* |
Draft Pharma
Policy to go for cabinet approval soon, without major changes |
Year 2006 |
* |
SSI ministry
suggests to slow down Schedule M implementation |
* |
Aurangabad bench
of Bombay HC stays implementation of Schedule M |
* |
Valuation
of Physicians' samples for Excise Duty. |
* |
Chemicals Ministry
may recommend full tax exemption for 33 HIV drugs |
* |
Pharma industry
opposes move to mandate bi-lingual labels |
* |
Pharma companies
rush for product licences fearing strict central licensing norms. |
* |
First meeting
of the Drug Advisory Forum |
* |
The
National Pharmaceutical Pricing Authority has fixed / revised the prices
in respect of 153 formulation packs vide notifications / orders dated 7.2.06.
|
* |
Budget 2006-'07,
a rude shock for Karnataka pharma sector |
* |
Budget neglects
SSI sector in pharma industry, say industry bodies |
* |
Pharma industry
totally disappointed with Budget as most of its proposals
rejected |
* |
CIPI expresses
shock over Budget, fears imminent closure of SSIs |
* |
License renewal
of SSIs in trouble as fund for schedule M implementation not operationalised
|
* |
Paswan seeks
FM's urgent intervention in solving problems of SSI units |
* |
Move to bring
in bi-lingual labelling on drugs may get stuck in health ministry |
* |
CIPI warns 'contempt
of court' action on state drug depts on issue of closure orders under Sch
M |
* |
Credit Linked
Capital Subsidy Scheme |
* |
CIPI to approach
finance ministry seeking cut in excise duty to 8% in Pharma Policy |
* |
SSIs sceptical
of CII's proposal to set up cGMP facility for pharma industry |
* |
NPPA fixes
price of Cefadroxyl Monohydrate |
* |
K'taka SSIs
turn desperate as Central Govt refusing to rectify anomaly in excise duty
structure |
* |
Pondicherry
FDA to take action against Schedule M non-compliant units by mid-April
|
* |
Health ministry
notifies final list of Schedule H with 536 drugs (Download) |
* |
NPPA
has fixed/revised the prices of 333 formulation packs on 29th March, 2006
(Download)
|
* |
Drug prices
spiral, thanks to excise waiver in HP, Uttaranchal |
* |
In spite of
tax holiday, drug prices soar |
* |
Health ministry
seeks cabinet nod for CDA, states not keen on centralizing drug administration
|
* |
Indian pharma
sector to grow by 11% in 2007-08: Assocham |
* |
K'taka's 19
out of 241 pharma units to be shut down for non-compliance to Sch. M
|
* |
Industry, trade
moots uniform trade margins for all categories of drugs |
* |
Chemicals ministry
asks industry to start process of bi-lingual labelling by April 18
|
* |
CIPI produces
data to show drug prices in excise free zones higher by 100% over other
areas |
* |
Criteria for
excise exemption for SSIs challenged in Punjab & Haryana HC |
* |
PM to convene
meeting of related central ministries to finalize Pharma Policy |
* |
Union govt
announces further 5 % abatement on MRP, no reduction on 16% excise duty
|
* |
WHO may assist
preparation of state level database of drug brands |
* |
PMO asks chemical
ministry to verify price variations of drugs made at excise free zones
|
* |
Drugs in
excise-free zones costlier |
* |
At what price?
|
* |
MRP inclusive
of all taxes may be effective for medicines from July 1 |
* |
New Foreign Trade
Policy 2006-07 |
* |
MRP inclusive
of taxes may expose drugs to WMA scrutiny |
* |
Chemical Ministry
proposes MAPE at 150% |
* |
Price control
on 354 essential drugs likely |
* |
IP edition to
have 98 new monographs, IPC invites proposals for addition / deletion
|
* |
Software for
pharma industry from Microsoft |
* |
CIPI seeks PM's
intervention on excise duty issues |
* |
354 drugs to
be put under price control |
* |
CIPI seeks standard
terms & conditions for all govt tenders of medicines |
* |
Pharma labels
to sport Hindi names |
* |
NPPA to have
regional advisory forums, policy proposal to be finalized next week
|
* |
Only new medicine
packs sold from July 1 need to have MRP inclusive of taxes stipulation
|
* |
NPPA may have
to revise ceiling prices to factor MRP inclusive of taxes |
* |
Shift in excise
duty policy on MRP of medicines hits small-scale units - Units shift base
to hill states |
* |
Govt in major
revenue loss in excise free zones as many pharma cos flock for duty evasion
|
* |
Price controls
may have drug firms convalescing |
* |
Chandigarh`s
small pharma units feel excise sops heat |
* |
Move to bring
more drugs under price control may affect drug availability, aggravate industry
woes |
* |
Political considerations
may cause extension of fiscal benefits to hill states |
* |
NPPA fixes prices
of 256 formulation packs |
* |
Latest
Clarification regarding computation of one crore central exemption limit |
* |
NPPA
Circular regarding submission of Price List |
* |
DCGI directs
DCs to cancel mfg licenses of diclofenac for veterinary use, phase out in
3 months |
* |
Free for
all in Himachal |
* |
IDMA appeals
for exemption of SSIs from price control in new policy |
* |
Centre may fix
Oct 2 as deadline for MRP inclusive regime in drugs trade |
* |
Concern of
Industry |
* |
Excise exemption
to be limited to drugs approved before March 31, 2007 in duty free states
|
* |
Drug shortage
likely if govt stick to Oct 2 for phase out of stocks without MRP inclusive
label |
* |
New pharma policy
to go easy on price control
|
* |
Drug MRP to
include all taxes from Oct 2 |
* |
Health Ministry
cautions against increasing span of price control in proposed drug policy
|
* |
Panel for reducing
excise on drugs |
* |
New order may
not control medicine prices |
* |
Draft drug policy
riddled with ambiguities, NPPA may find tough to fix ceiling on MRPs
|
* |
The
ministry of chemicals and fertilisers has given the pharmaceutical industry
more time to implement labelling changes in products. |
* |
CIPI to protest
implementation of MRP inclusive taxes regime if the issues not resolved
|
* |
Business starved
SSIs initiate aggressive campaign to do away turnover criteria for tender
process |
* |
Govt may have
to amend MRP notification to avoid implementation hurdles |
* |
Planning Commission
panel on drug industry to meet on July 14 |
* |
Drug industry
opposes new draft policy |
* |
OPPI opposes draft
National Pharmaceuticals Policy |
* |
Span of price
control would go up only by 8% in new policy: Paswan |
* |
CIPI suggests
50% cap on Cenvat credit on medicines |
* |
New pharma policy
misses the larger picture With its narrow price control view, such a policy
will create market distortions and hurt R&D |
* |
Commerce and
industry ministry oppose the controversial move to bring 663 formulations
under price control |
* |
Pharma cos may
have to choose two options in MRP inclusive regime |
* |
Government
invites comments on Proposed Amendments to NDPS Rules, 1985 |
* |
IDMA demands
to notify revised ceiling prices to comply with MRP inclusive of taxes regime
|
* |
Chemicals ministry
in talks with govts of AP, WB, Gujarat to set up NIPER like bodies |
* |
Indian Pharmacopoeia
signs MoU with US |
* |
Industry assns
to move against extension of excise exemption |
* |
PMO opposes
move to bring all NLEM drugs under price control |
* |
Now, govt plans
pharma parks |
* |
TN DCA orders
closure of 100 Schedule M non-compliant pharma units |
* |
ORG finds 0.7%
price increase in NLEM drugs in 3 years |
* |
Drug Pricing:
Cos to meet Paswan |
* |
WHO issues
guidelines on use of cotrimoxazole prophylaxis |
* |
Paswan forms
new committee to review contentious issues of Pharma Policy 2006 |
* |
Trade to pursue
implementation of uniform trade margins for all drugs |
* |
Firms accept
margin cap for unbranded generics |
* |
Schedule K amendment
notified, Aspirin, Quinine out of household remedies list |
* |
Chemicals ministry
calls meeting industry leaders on MRP, bilingual labelling on August 24
|
* |
Drug makers
refuse to take call on MRP printing |
* |
Chemicals ministry
may consult law ministry on SC ruling to make essential drugs affordable
|
* |
India is the
only nation to adopt cost-based price control system |
* |
Drug makers
may be allowed to print MRP inclusive of taxes even before Oct 2 deadline
|
* |
IPA to submit
sample bilingual packs by Sep 20 |
* |
Govt & industry
spar over drug price control |
* |
NPPA finds no
major fluctuations in prices of non-scheduled formulations in 3 years
|
* |
Draft drug policy
review committee to meet on Sep 20 in Mumbai |
* |
Drug manufacturers
resent tax holiday in 3 states |
* |
Chemicals ministry
to seek Law ministry's interpretation of SC verdict on NLEM drugs |
* |
Government relaxes
rules on MRP labelling |
* |
Govt may relent
on drug price control |
* |
Pharma sector
may have to spend Rs 500 cr for adding 'MRP inclusive of all taxes' on label
|
* |
CIPI offers
free drugs for BPL families |
* |
HCL launches
eCompliance for Pharmaceutical Firms; eCompliance Suite Helps Manage and
Shorten the Complex Regulatory Document Submission Cycle for New Products |
* |
DCGI clears
44 fixed dose combinations in 2005-06 |
* |
Paswan to stick
to drug duty cut plan |
* |
Industry to
pitch for price monitoring, roll back of excise to 8% |
* |
Pharma industry
stands to lose Rs.330 cr with new MRP regime |
* |
Centre plans
comprehensive amendment to D&C Act to strengthen rules on export quality
of drugs |
* |
Chemicals Dept
to verify industry claims on price |
* |
Centre may levy service tax
on contract manufacturing units in excise free zones |
* |
IDMA's pre-budget
memorandum seeks excise cut on allopathic, ayurvedic drugs |
* |
Industry demands
hike in abatement to 52% to cut losses due to MRP regime |
* |
Draft policy
review committee to finalize recommendations in three weeks |
* |
Drugs price
control bill trespasses into exclusive domain of D&C Act |
* |
Draft policy
review panel may suggest short & long term strategies to enforce price
control |
* |
Drug policy
review panel to meet on Nov 25, recommendations by 30th |
* |
Finance ministry
may grant nominal hike in abatement rate, not 52 % |
* |
CIPI, CPMA MoU
soon to boost Indo-Chinese pharma relations |
* |
Drug policy
panel submits tentative report, ministry buys more time on policy |
* |
Tax Concessions
to Pharma Companies |
* |
NLEM as drugs
for price control in pharma policy |
* |
SSI pharmas
may get excise cut placebo |
* |
PDMA demands
implementation of Dr Pronab Sen and Dr Rangarajan proposals |
* |
Govt move
to introduce GLP norms may hasten closure of more SSIs |
| * |
Centre to
make compulsory filing of ISM raw material data with Central, State agencies |
| * |
CIPI fears
trade margin clause in new drug policy may turn detrimental to SSIs |
* |
Parliamentary
Panel on Schedule M implementation to submit report next month |
* |
NPPA cuts
prices of bethamethasone derivatives, hikes ranitidine price |
* |
Centre now
says bi-lingual labeling only a voluntary provision |
* |
GLP implementation
may force another 1000 SSIs to close down in 2007 |
